Do you know about Vertex Guidance & Patient Support?
Vertex Guidance & Patient Support (Vertex GPS™) provides eligible patients with product support. This includes information about insurance coverage and financial assistance for patients who are 2 years of age and older, have a G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549R, or R117H mutation in their CF gene, and have a prescription for KALYDECO® (ivacaftor). Caregivers of patients younger than 18 years of age must be the patient’s parent or legal guardian.
Your Vertex GPS Case Manager can provide ongoing communications from the Vertex GPS program, including educational materials about your prescription for KALYDECO.
To speak with a trained Vertex GPS Case Manager and learn more, call
Visit Vertex GPS at www.VertexGPS.com.
What is KALYDECO® (ivacaftor)?
KALYDECO is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age 2 years and older who have one of the following mutations in their CF gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R.
KALYDECO is used for the treatment of CF in patients age 2 years and older who have an R117H mutation in their CF gene.
KALYDECO is not for use in people with CF due to other mutations in the CF gene. KALYDECO is not effective in patients with CF with two copies of the F508del mutation (F508del/F508del) in the CF gene.
It is not known if KALYDECO is safe and effective in children under 2 years of age.
Important Safety Information
Who should not take KALYDECO?
Do not take KALYDECO if you take certain medicines or herbal supplements such as: the antibiotics rifampin (Rifamate®, Rifater®) or rifabutin (Mycobutin®); seizure medications such as phenobarbital, carbamazepine (Tegretol®, Carbatrol®, Equetro®) or phenytoin (Dilantin®, Phenytek®); or St. John’s wort.
Talk to your doctor before taking KALYDECO if you take any of these medicines or supplements.